Search
for
Sort by
Research 421–450 of 1000+
- Pre‐clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer
- Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Endocrine correlates of male breast cancer risk: a case-control study in Athens, Greece
- Relationship Between Male Pattern Baldness and the Risk of Aggressive Prostate Cancer: An Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
- Natural products reverse cancer multidrug resistance
- Curcumin and cancer biology: Focusing regulatory effects in different signalling pathways
- Permanent hair dyes and bladder cancer risk
- Diagnosis of breast cancer by X-ray diffraction of hair
- Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
- Liposomes in cancer therapy
- Skin toxicity of anti‐cancer therapy
- The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis
- The Bio-Safety Concerns of Three Domestic Temporary Hair Dye Molecules: Fuchsin Basic, Victoria Blue B and Basic Red 2
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers
- Premature aging and cancer development in transgenic mice lacking functional CYLD
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- High-confidence cancer patient stratification through multiomics investigation of DNA repair disorders
- Changes in scalp hair after cancer chemotherapy
- Androgen- and Estrogen-Secreting Adrenal Cancers
- Resistance Exercise and Art Therapy on Body Image in Breast Cancer: A Scoping Review
- Hair loss during and after breast cancer therapy
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?
- Diagnostic applications and therapeutic option of Cascade CRISPR/Cas in the modulation of miRNA in diverse cancers: promises and obstacles
- Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues